Upstream Bio, Inc.
UPB
$9.71
$0.9310.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -62.81M | -53.40M | -40.51M | -30.52M | -20.54M |
| Total Depreciation and Amortization | 89.00K | 54.00K | 57.00K | 58.50K | 60.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.67M | -1.49M | -7.58M | -10.36M | -13.14M |
| Change in Net Operating Assets | 1.87M | -837.00K | 1.50M | -1.40M | -4.31M |
| Cash from Operations | -59.17M | -55.67M | -46.53M | -42.23M | -37.93M |
| Capital Expenditure | -511.00K | -326.00K | 0.00 | -72.00K | -144.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.97M | -106.31M | -95.80M | -89.25M | -82.70M |
| Cash from Investing | -59.49M | -106.64M | -95.80M | -89.32M | -82.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 272.88M | 131.00K | 212.00K | 165.00K | 118.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 150.00M | 149.92M | 149.92M | 139.77M | 129.62M |
| Repurchase of Preferred Stock | -- | -133.00K | -183.00K | -183.00K | -183.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.97M | -1.79M | -133.00K | -66.50K | -- |
| Cash from Financing | 418.91M | 148.13M | 149.82M | 139.69M | 129.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 300.25M | -14.18M | 7.50M | 8.14M | 8.78M |